產(chǎn)品名稱 | 磷酸化乳腺癌易感基因1抗體 |
英文名稱 | Anti-Phospho-BRCA1(Ser988) |
規(guī)格 | 0.1ml/100μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-Phospho-BRCA1(Ser988)
中文名稱 磷酸化乳腺癌易感基因1抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡
蛋白分子量 predicted molecular weight: 208kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derivedfrom human BRCA1 around the phosphorylation site of Ser998
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -73 °C for oneyear.
別 名 BRCA1 (Phospho-Ser988); BRCA1 (phospho S988); p-BRCA1(phospho S988); BRCA 1; BRCA1; BRCA1/BRCA2 containing complex subunit 1;BRCA1/BRCA2-containing complex, subunit 1; BRCA1_HUMAN; BRCAI; BRAC 1; BRCA 1;BRCC 1; BRCC1; Breast Cancer 1; Breast Cancer 1 Early Onset; Breast cancer type1 susceptibility protein; Breast and ovarian cancer susceptibility protein 1;Breast Ovarian Cancer Susceptibility; IRIS; Papillary Serous Carcinoma Of ThePeritoneum; PSCP; RING finger protein 53; BROVCA1; IRIS; PNCA4; PPP1R53;Protein phosphatase 1 regulatory subunit 53; RNF53; BAP1.
